{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:58:11Z","timestamp":1771037891312,"version":"3.50.1"},"reference-count":31,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.11172","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:49:12Z","timestamp":1575287352000},"source":"Crossref","is-referenced-by-count":6,"title":["An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer"],"prefix":"10.3892","author":[{"given":"Tomoharu","family":"Naito","sequence":"first","affiliation":[{"name":"Pharmaceutical and Healthcare Research Laboratories, FUJIFILM Corporation, Ashigarakami\u2011gun, Kanagawa 258\u20118577, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamami","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Pharmaceutical and Healthcare Research Laboratories, FUJIFILM Corporation, Ashigarakami\u2011gun, Kanagawa 258\u20118577, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Shimada","sequence":"additional","affiliation":[{"name":"Pharmaceutical and Healthcare Research Laboratories, FUJIFILM Corporation, Ashigarakami\u2011gun, Kanagawa 258\u20118577, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihaya","family":"Kakinuma","sequence":"additional","affiliation":[{"name":"Pharmaceutical and Healthcare Research Laboratories, FUJIFILM Corporation, Ashigarakami\u2011gun, Kanagawa 258\u20118577, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"key20200714105833_b1-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/1097-0142(19950101)75:1+<316::AID-CNCR2820751314>3.0.CO;2-T","article-title":"Urinary system","volume":"75","author":"Lynch","year":"1995","journal-title":"Cancer"},{"key":"key20200714105833_b2-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/CCO.0b013e3282f8b03e","article-title":"Bladder cancer","volume":"20","author":"Barocas","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"key20200714105833_b3-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: Epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"key20200714105833_b4-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3322\/caac.20077","article-title":"Bladder cancer in 2010: How far have we come?","volume":"60","author":"Jacobs","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"key20200714105833_b5-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/1097-0142(19820801)50:3<515::AID-CNCR2820500323>3.0.CO;2-Q","article-title":"The origin of invasive carcinoma of the bladder","volume":"50","author":"Brawn","year":"1982","journal-title":"Cancer"},{"key":"key20200714105833_b6-ol-0-0-11172","first-page":"1","article-title":"The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma. Hinyokika kiyo","volume":"47","author":"Kanematsu","year":"2001","journal-title":"Acta urologica Japonica (Japanese)"},{"key":"key20200714105833_b7-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0090-4295(77)90227-8","article-title":"Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: Further studies of surgically removed bladders by mapping","volume":"9","author":"Koss","year":"1977","journal-title":"Urology"},{"key":"key20200714105833_b8-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jama.1974.03230160009002","article-title":"Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders","volume":"227","author":"Koss","year":"1974","journal-title":"JAMA"},{"key":"key20200714105833_b9-ol-0-0-11172","first-page":"S39","article-title":"Review of mayo clinic experience with carcinoma in situ","volume":"26","author":"Zincke","year":"1985","journal-title":"Urology"},{"key":"key20200714105833_b10-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrurol.2015.58","article-title":"Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer","volume":"12","author":"Kamat","year":"2015","journal-title":"Nat Rev Urol"},{"key":"key20200714105833_b11-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.eururo.2006.05.035","article-title":"Improving efficacy of intravesical chemotherapy","volume":"50","author":"Gasi\u00f3n","year":"2006","journal-title":"Eur Urol"},{"key":"key20200714105833_b12-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1186\/s12885-017-3778-3","article-title":"An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: Influence of mouse strain, tumor cell count, dwell time and bladder pretreatment","volume":"17","author":"Huebner","year":"2017","journal-title":"BMC Cancer"},{"key":"key20200714105833_b13-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/cas.12662","article-title":"Adaptor protein CRK induces epithelial-mesenchymal transition and metastasis of bladder cancer cells through HGF\/c-Met feedback loop","volume":"106","author":"Matsumoto","year":"2015","journal-title":"Cancer Sci"},{"key":"key20200714105833_b14-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.eururo.2011.05.005","article-title":"Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis","volume":"60","author":"van der Horst","year":"2011","journal-title":"Eur Urol"},{"key":"key20200714105833_b15-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1172\/JCI23043","article-title":"Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer","volume":"115","author":"Nogawa","year":"2005","journal-title":"J Clin Invest"},{"key":"key20200714105833_b16-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.3892\/ol.2017.6004","article-title":"Periostin suppresses in vivo invasiveness via PDK1\/Akt\/mTOR signaling pathway in a mouse orthotopic model of bladder cancer","volume":"13","author":"Kim","year":"2017","journal-title":"Oncol Lett"},{"key":"key20200714105833_b17-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/j.1464-410X.2009.08577.x","article-title":"Mouse orthotopic models for bladder cancer research","volume":"104","author":"Chan","year":"2009","journal-title":"BJU Int"},{"key":"key20200714105833_b18-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/0471141755.ph1414s49","article-title":"Mouse models of human bladder cancer as a tool for drug discovery","volume":"49","author":"Seager","year":"2010","journal-title":"Curr Protoc Pharmacol"},{"key":"key20200714105833_b19-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3892\/ol.2015.2888","article-title":"Animal models for bladder cancer: The model establishment and evaluation (Review)","volume":"9","author":"Zhang","year":"2015","journal-title":"Oncol Lett"},{"key":"key20200714105833_b20-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrc3858","article-title":"Modelling bladder cancer in mice: Opportunities and challenges","volume":"15","author":"Kobayashi","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"key20200714105833_b21-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1158\/0008-5472.CAN-08-3530","article-title":"A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression","volume":"69","author":"Shimada","year":"2009","journal-title":"Cancer Res"},{"key":"key20200714105833_b22-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/sj.cgt.7700489","article-title":"Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression","volume":"9","author":"Zhou","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"key20200714105833_b23-ol-0-0-11172","article-title":"JoVE Science Education Database. Lab Animal Research","volume-title":"Anesthesia Induction and Maintenance","year":"2019"},{"key":"key20200714105833_b24-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1259\/dmfr\/37174063","article-title":"Establishment of temporomandibular joint puncture technique in rats using in vivo micro-computed tomography (R_mCT(R))","volume":"39","author":"Kameoka","year":"2010","journal-title":"Dentomaxillofac Radiol"},{"key":"key20200714105833_b25-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/cas.12872","article-title":"Establishment of a novel method to evaluate peritoneal microdissemination and therapeutic effect using luciferase assay","volume":"107","author":"Takahashi","year":"2016","journal-title":"Cancer Sci"},{"key":"key20200714105833_b26-ol-0-0-11172","first-page":"3091","article-title":"Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT2 pancreatic cancer mouse model","volume":"15","author":"Higuchi","year":"2017","journal-title":"Oncol Lett"},{"issue":"pii","key":"key20200714105833_b27-ol-0-0-11172","first-page":"2535","article-title":"An orthotopic model of murine bladder cancer","author":"Dobek","year":"2011","journal-title":"J Vis Exp"},{"key":"key20200714105833_b28-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1200\/JCO.2001.19.10.2638","article-title":"Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924","volume":"19","author":"Sternberg","year":"2001","journal-title":"J Clin Oncol"},{"key":"key20200714105833_b29-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"1758835918788310","DOI":"10.1177\/1758835918788310","article-title":"Approved checkpoint inhibitors in bladder cancer: which drug should be used when?","volume":"10","author":"Ghatalia","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"key20200714105833_b30-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"von der Maase","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20200714105833_b31-ol-0-0-11172","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:12:33Z","timestamp":1594721553000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.11172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.11172","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]}}}